RE:SCOTIABANK CUTSthis is a really detailed update by Scotia on the company and goes right down to projected balance sheets for 2017 where they point out that CXR is trading at 2.7 times 2017 free cash flow of $US 5.30 or $CDN 6.89
they call it a long term investment and Sector outperform.
Brexit has hit this a lot, with Scotia talking more haircut on guidance from US drug sales than RBC, but again, as with RBC, most of the net decline is all FX and the No vote.
for those who want to see the Scotia, it is part of their Daily Edge reporting package - about 5 pages of it in fact!